Use of low-dose gabapentin for aggressive behavior in vascular and Mixed Vascular/Alzheimer Dementia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 25, Issue 2, 2013, Pages 120-125

  Cooney, Colm ^a   Murphy, Sinead ^a   Tessema, Hiberet ^a   Freyne, Aideen ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DONEPEZIL; GABAPENTIN; MEMANTINE; QUETIAPINE;

ABSENCE OF SIDE EFFECTS; AGED; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; ICD-10; LOW DRUG DOSE; MALE; NURSING HOME; NURSING HOME PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR;

AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; AMINES; CYCLOHEXANECARBOXYLIC ACIDS; DEMENTIA, VASCULAR; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; RETROSPECTIVE STUDIES;

EID: 84883270820     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12050115     Document Type: Article

References (24)

1. Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293:596-608
2. Hall KA, O'Connor DW: Correlates of aggressive behavior in dementia. Int Psychogeriatr 2004; 16:141-158
3. Gauthier S, Cummings J, Ballard C, et al: Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr 2010; 22:346-372
4. Jeste DV, Lacro JP: Characteristics of an ideal drug for behavioral and psychological symptoms of dementia. Int Psychogeriatr 2008; 12(Suppl 1):213-215
5. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14:191-210
6. Banerjee S: The Use of Antipsychotic Medication for People with Dementia: Time for Action. London, UK, Department of Health, 2009
7. Eustace A, Coen R, Walsh C, et al: A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int J Geriatr Psychiatry 2002; 17:968-973
8. Tariot PN, Erb R, Leibovici A, et al: Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42:1160-1166
9. Cooney C, Mortimer A, Smith A, et al: Carbamazepine use in aggressive behavior associated with senile dementia. Int J Geriatr Psychiatry 1996; 11:901-905
10. Tariot PN, Erb R, Podgorski CA, et al: Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998; 155:54-61
11. Olin JT, Fox LS, Pawluczyk S, et al: A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer's disease. Am J Geriatr Psychiatry 2001; 9:400-405
12. Konovalov S, Muralee S, Tampi RR: Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr 2008; 20:293-308
13. Sajatovic M, Madhusoodanan S, Coconcea N: Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging 2005; 22:39-54
14. Kim Y, Wilkins KM, Tampi RR: Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs Aging 2008; 25:187-196
15. Hardy J, Cowburn R, Barton A, et al: A disorder of cortical GABAergic innervation in Alzheimer's disease. Neurosci Lett 1987; 73:192-196
16. Regan WM, Gordon SM: Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol 1997; 17:59-60
17. Lanctôt KL, Herrmann N, Mazzotta P, et al: GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiatry 2004; 49:439-453
18. Miller LJ: Gabapentin for treatment of behavioral and psychological symptoms of dementia. Ann Pharmacother 2001; 35:427-431
19. Alkhalil C, Tanvir F, Alkhalil B, et al: Treatment of sexual disinhibition in dementia: case reports and review of the literature. Am J Ther 2004; 11:231-235
20. World Health Organisation: ICD-10 Classifications of Mental and Behavioral Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland, World Health Organisation, 1992
21. Hawkins JW, Tinklenberg JR, Sheikh JI, et al: A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry 2000; 8:221-225
22. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
23. Rossi P, Serrao M, Pozzessere G: Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with Lewy bodies: case reports. Eur Neurol 2002; 47:56-57
24. Silvestrelli G, Corea F, Micheli S, et al: Clinical pharmacology and vascular risk. Open Neurol J 2010; 4:64-72